Radiomitigating pharmaceutical formulations
US-2016090369-A1 · Mar 31, 2016 · US
US9840483B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9840483-B2 |
| Application number | US-201615094192-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 8, 2016 |
| Priority date | May 7, 2013 |
| Publication date | Dec 12, 2017 |
| Grant date | Dec 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.
Opening claim text (preview).
We claim: 1. A method of mitigating an effect of ionizing radiation on a cell, organ, tissue, or organism, comprising contacting the cell, organ, tissue, or organism with a compound having the structure of Formula II: wherein: Y 1 and Y 2 taken together with X form: and wherein: X is N; G is selected from N or —C(H)—; Z is absent or selected from substituted or unsubstituted alkyl, heteroalkyl, alkenyl, or alkynyl; R 4 is absent or selected from substituted or unsubstituted aryl; and R 5 and R 6 are each independently absent or lower alkyl. 2. The method of claim 1 , wherein G is N and R 4 is selected from phenyl, 4-fluorophenyl and 3-chlorophenyl. 3. The method of claim 1 , wherein Z is absent. 4. The method of claim 1 , wherein Z is prop-2-en-1-yl and R 4 is phenyl. 5. The method of claim 1 , wherein the compound is selected from the group consisting of compounds 1, 2, 3, 4, 7, 8, 9, and 10 of Table 1. 6. The method of claim 1 , wherein the compound has the structure: 7. The method of claim 1 , wherein the organism is a mammal. 8. A method of treating inflammation in an organism, comprising administering to the organism a compound having the structure of Formula II: wherein: Y 1 and Y 2 taken together with X form: and wherein: X is N; G is selected from N or —C(H)—; Z is absent or selected from substituted or unsubstituted alkyl, heteroalkyl, alkenyl, or alkynyl; R 4 is absent or selected from substituted or unsubstituted aryl; and R 5 and R 6 are each independently absent or lower alkyl. 9. The method of claim 8 , wherein G is N and R 4 is selected from phenyl, 4-fluorophenyl and 3-chlorophenyl. 10. The method of claim 8 , wherein Z is absent. 11. The method of claim 8 , wherein Z is prop-2-en-1-yl and R 4 is phenyl. 12. The method of claim 8 , wherein the compound is selected from the group consisting of compounds 1, 2, 3, 4, 7, 8, 9, and 10 of Table 1. 13. The method of claim 8 , wherein the compound has the structure: 14. The method of claim 8 , wherein the organism is a human. 15. A method of treating lung cancer in an organism, comprising administering to the organism a compound having the structure of Formula II: wherein: Y 1 and Y 2 taken together with X form: and wherein: X is N; G is selected from N or —C(H)—; Z is absent or selected from substituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted alkenyl, or substituted or unsubstituted alkynyl; R 4 is absent or selected from substituted or unsubstituted aryl; and R 5 and R 6 are each independently absent or lower alkyl. 16. The method of claim 15 , wherein G is N and R 4 is selected from phenyl, 4-fluorophenyl and 3-chlorophenyl. 17. The method of claim 15 , wherein Z is absent. 18. The method of claim 15 , wherein Z is prop-2-en-1-yl and R 4 is phenyl. 19. The method of claim 15 , wherein the compound is selected from the group consisting of compounds 1, 2, 3, 4, 8, 9, and 10 of Table 1. 20. The method of claim 15 , wherein the compound has the structure: 21. The method of claim 13 , wherein the organism is a human.
Antineoplastic agents · CPC title
Free radical scavengers or antioxidants · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
attached in position 3 · CPC title
Sulfur atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.